Kirkland, Mylan Lay Down Arms In Teva Representation Fight
One week after Teva Pharmaceutical Industries Ltd. abandoned its hostile bid for Mylan NV to instead snap up a unit of Allergan plc for $40.5 billion, Mylan and Kirkland & Ellis...To view the full article, register now.
Already a subscriber? Click here to view full article